181 related articles for article (PubMed ID: 19377492)
21. [Efficacy of ivabradine in patients with stable angina and comorbid chronic obstructive pulmonary disease].
Khamaeva AA; Belialov FI; Kerzina LV; Berezovskaia OV; Parshukova ED; Zakharova GIu
Kardiologiia; 2012; 52(1):15-9. PubMed ID: 22304347
[TBL] [Abstract][Full Text] [Related]
22. Antianginal and antiischemic effects of ivabradine, an I(f) inhibitor, in stable angina: a randomized, double-blind, multicentered, placebo-controlled trial.
Borer JS; Fox K; Jaillon P; Lerebours G;
Circulation; 2003 Feb; 107(6):817-23. PubMed ID: 12591750
[TBL] [Abstract][Full Text] [Related]
23. Efficacy of ivabradine in combination with Beta-blocker versus uptitration of Beta-blocker in patients with stable angina.
Amosova E; Andrejev E; Zaderey I; Rudenko U; Ceconi C; Ferrari R
Cardiovasc Drugs Ther; 2011 Dec; 25(6):531-7. PubMed ID: 21830063
[TBL] [Abstract][Full Text] [Related]
24. Selective and specific I(f) inhibition: new perspectives for the treatment of stable angina.
Fox K
Expert Opin Pharmacother; 2006 Jun; 7(9):1211-20. PubMed ID: 16732707
[TBL] [Abstract][Full Text] [Related]
25. [Symptomatic coronary heart diseases. Combination therapy is successful in general practice].
MMW Fortschr Med; 2014 Nov; 156(20):75. PubMed ID: 25543378
[No Abstract] [Full Text] [Related]
26. Novel therapeutic approaches to treating chronic angina in the setting of chronic ischemic heart disease.
Chaitman BR; Sano J
Clin Cardiol; 2007 Feb; 30(2 Suppl 1):I25-30. PubMed ID: 18373327
[TBL] [Abstract][Full Text] [Related]
27. Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial.
Chaitman BR; Pepine CJ; Parker JO; Skopal J; Chumakova G; Kuch J; Wang W; Skettino SL; Wolff AA;
JAMA; 2004 Jan; 291(3):309-16. PubMed ID: 14734593
[TBL] [Abstract][Full Text] [Related]
28. [A possibility to interchange heart rate-slowing therapy with ivabradine and atenolol in patients with stable angina pectoris].
Shavarov AA; Kiiakbaev GK; Kobalava ZhD
Ter Arkh; 2013; 85(4):77-83. PubMed ID: 23808298
[TBL] [Abstract][Full Text] [Related]
29. β-Blockers and ivabradine differentially affect cardiopulmonary function and left ventricular filling index.
Fischer-Rasokat U; Honold J; Lochmann D; Wolter S; Liebetrau C; Fichtlscherer S; Möllmann H; Spyridopoulos I; Hamm CW
Clin Res Cardiol; 2016 Jun; 105(6):527-34. PubMed ID: 26687495
[TBL] [Abstract][Full Text] [Related]
30. Ivabradine in patients with inappropriate sinus tachycardia.
Zellerhoff S; Hinterseer M; Felix Krull B; Schulze-Bahr E; Fabritz L; Breithardt G; Kirchhof P; Kääb S
Naunyn Schmiedebergs Arch Pharmacol; 2010 Dec; 382(5-6):483-6. PubMed ID: 20859616
[TBL] [Abstract][Full Text] [Related]
31. Treatment of chronic angina pectoris with combination mibefradil and beta-blocker therapy.
Alpert JS
Clin Cardiol; 1998 Feb; 21(2):129. PubMed ID: 9491954
[No Abstract] [Full Text] [Related]
32. Comparison of controlled-onset, extended-release verapamil with amlodipine and amlodipine plus atenolol on exercise performance and ambulatory ischemia in patients with chronic stable angina pectoris.
Frishman WH; Glasser S; Stone P; Deedwania PC; Johnson M; Fakouhi TD
Am J Cardiol; 1999 Feb; 83(4):507-14. PubMed ID: 10073852
[TBL] [Abstract][Full Text] [Related]
33. Comparative efficacy of ranolazine versus atenolol for chronic angina pectoris.
Rousseau MF; Pouleur H; Cocco G; Wolff AA
Am J Cardiol; 2005 Feb; 95(3):311-6. PubMed ID: 15670536
[TBL] [Abstract][Full Text] [Related]
34. Ivabradine versus bisoprolol.
Fazio G; Sarulo F; Licata P; D'Angelo L; Passantino S; Visconti C; Zarcone P; Spanò C; Novo G; Novo S
Minerva Cardioangiol; 2010 Apr; 58(2):281-2. PubMed ID: 20440257
[No Abstract] [Full Text] [Related]
35. Ivabradine: a selective If current inhibitor in the treatment of stable angina.
Andrikopoulos G; Dasopoulou C; Sakellariou D; Tzeis S; Koulouris S; Kranidis A; Kappos K; Manolis AS
Recent Pat Cardiovasc Drug Discov; 2006 Nov; 1(3):277-82. PubMed ID: 18221092
[TBL] [Abstract][Full Text] [Related]
36. [Ivabradine--the first selective and specific I(f) inhibitor, novel preparation for treatment of stable angina].
Belousov IuB; Erofeeva SB; Maneshina OA
Kardiologiia; 2006; 46(8):36-48. PubMed ID: 17047598
[TBL] [Abstract][Full Text] [Related]
37. Ivabradine: beyond heart rate control.
Riccioni G; Vitulano N; D'Orazio N
Adv Ther; 2009 Jan; 26(1):12-24. PubMed ID: 19165437
[TBL] [Abstract][Full Text] [Related]
38. Effectiveness and Tolerability of Ivabradine with or Without Concomitant Beta-Blocker Therapy in Patients with Chronic Stable Angina in Routine Clinical Practice.
Perings S; Stöckl G; Kelm M;
Adv Ther; 2016 Sep; 33(9):1550-64. PubMed ID: 27432382
[TBL] [Abstract][Full Text] [Related]
39. Ivabradine: I(f) inhibition in the management of stable angina pectoris and other cardiovascular diseases.
Tardif JC
Drugs Today (Barc); 2008 Mar; 44(3):171-81. PubMed ID: 18536779
[TBL] [Abstract][Full Text] [Related]
40. Safe and well-tolerated treatment with ivabradine in systemic sclerosis affected by pulmonary hypertension.
Correale M; Montrone D; Biase MD; Brunetti ND
Clin Res Cardiol; 2012 Jul; 101(7):593-4. PubMed ID: 22383181
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
